Finance

Lists
Q2 2026 earnings • released • Revenue miss -4.70%
See results
EL:EPA
EssilorLuxottica SA
€164.05
+0.28%
(+0.45) 1D
Jul 31, 5:35:52 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for EL...
Open
€161.65
High
€167.70
Low
€161.05
Mkt. cap
77.51B
Avg. vol.
706.65K
Volume
892.32K
P/E ratio
30.62
52-wk high
€323.80
52-wk low
€160.60
EPS
€5.36
Shares outstanding
464.25M
No. of employees
210K
Open
€161.65
High
€167.70
Low
€161.05
Mkt. cap
77.51B
Avg. vol.
706.65K
Volume
892.32K
P/E ratio
30.62
52-wk high
€323.80
52-wk low
€160.60
EPS
€5.36
Shares outstanding
464.25M
No. of employees
210K
News stories
From sources across the web
Profile
EssilorLuxottica SA is a Franco-Italian vertically integrated multinational holding company registered in Charenton-Le-Pont and headquartered both in Paris and Milan. It designs, produces and markets ophthalmic lenses, equipment and instruments, prescription glasses and sunglasses. It was founded on 1 October 2018, and its name is an amalgamation of the two major corporations which merged to create it; the French Essilor and the Italian Luxottica. The two companies have, since the merger, been restructured as subsidiaries of the new entity. Under the terms of the merger agreement, Essilor would purchase Luxottica, but Luxottica's leadership would be guaranteed prominent positions in the newly-formed corporation as well as some seats on its board of directors; the Luxottica founder, Leonardo Del Vecchio, was notably designated chairman. The first few years of EssilorLuxottica post-merger were marred by disputes over leadership roles, but Del Vecchio was able to bring them to a satisfactory end. Essilor and Luxottica were respectively the world's leading manufacturers of ophthalmic lenses and of eyeglasses; upon the merger, EssilorLuxottica thus became a monopoly. Wikipedia
About EssilorLuxottica SA
CEOFrancesco Milleri
Employees210K
FoundedOct 1, 2018
Headquarters-
SectorMedical device
Last report
Jul 28, 2026
Fiscal period
Q2 2026
EPS / Est. (EUR)
- / -
Revenue / Est. (EUR)
7.41B / 7.77B
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
7.23B
7.23B
7.41B
7.41B
Cost of goods sold
3.08B
3.08B
2.78B
2.78B
Cost of revenue
3.08B
3.08B
2.78B
2.78B
Research and development expenses
169.00M
169.00M
166.50M
166.50M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.26B
3.26B
3.34B
3.34B
Operating expense
3.42B
3.42B
3.49B
3.49B
Total operating expenses
6.50B
6.50B
6.26B
6.26B
Operating income
737.50M
737.50M
1.15B
1.15B
Other non operating income
-9.50M
-9.50M
22.00M
22.00M
EBT including unusual items
639.50M
639.50M
1.09B
1.09B
EBT excluding unusual items
688.00M
688.00M
1.09B
1.09B
Income tax expense
144.50M
144.50M
271.00M
271.00M
Effective tax rate
22.60%
22.60%
24.81%
24.81%
Other operating expenses
-9.00M
-9.00M
-22.00M
-22.00M
Net income
464.00M
464.00M
783.00M
783.00M
Net profit margin
6.41%
6.41%
10.57%
10.57%
Earnings per share
-
-
-
-
Interest and investment income
25.00M
25.00M
-
-
Interest expense
-83.50M
-83.50M
-77.50M
-77.50M
Net interest expenses
-58.50M
-58.50M
-77.50M
-77.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.26B
1.26B
1.94B
1.94B
Gain or loss from assets sale
1.50M
1.50M
-21.00M
-21.00M
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps